Geode Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-308,736
Closed -$217K 4642
2024
Q1
$217K Buy
308,736
+8,462
+3% +$9.56K ﹤0.01% 3916
2023
Q4
$526K Buy
300,274
+18,953
+7% +$27.7K ﹤0.01% 3599
2023
Q3
$405K Buy
281,321
+20,561
+8% +$51.4K ﹤0.01% 3680
2023
Q2
$678K Buy
260,760
+4,541
+2% +$13.6K ﹤0.01% 3512
2023
Q1
$943K Buy
256,219
+1,795
+0.7% +$7.56K ﹤0.01% 3376
2022
Q4
$450K Buy
254,424
+3,299
+1% +$8.78K ﹤0.01% 3702
2022
Q3
$994K Buy
251,125
+1,720
+0.7% +$10.6K ﹤0.01% 3390
2022
Q2
$1.38M Sell
249,405
-179,040
-42% -$1.47M ﹤0.01% 3271
2022
Q1
$6.29M Buy
428,445
+9,451
+2% +$126K ﹤0.01% 2662
2021
Q4
$6.62M Sell
418,994
-398
-0.1% -$9.56K ﹤0.01% 2728
2021
Q3
$13.5M Buy
419,392
+7,838
+2% +$275K ﹤0.01% 2247
2021
Q2
$17.1M Buy
411,554
+116,429
+39% +$4.78M ﹤0.01% 2078
2021
Q1
$15M Buy
295,125
+131,083
+80% +$6.86M ﹤0.01% 2062
2020
Q4
$5.32M Buy
164,042
+25,480
+18% +$361K ﹤0.01% 2571
2020
Q3
$1.66M Buy
138,562
+77,983
+129% +$904K ﹤0.01% 2970
2020
Q2
$801K Buy
+60,579
New +$789K ﹤0.01% 3216

Other funds holding DMTK

Geode Capital Management's DMTK Position: Q2 2024 in Review

Geode Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 308,736 shares — an estimated $217K sold.

Geode Capital Management first reported a position in DMTK in Q2 2020 and held it in 16 quarters. The position peaked at $17.1M in Q2 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Geode Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Geode Capital Management sold 308,736 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $217K.
  • Geode Capital Management first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • Geode Capital Management's DermTech, Inc. Common Stock position peaked at $17.1M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Geode Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.